Trade NYXH stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Nyxoah SA (NYXH) is trading at US$1.48, down 0.67% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$160.12M. Over the past 52 weeks, NYXH has traded between US$1.26 and US$6.87. On Syfe you can trade NYXH with $0 commission and add it to your watchlist.
| Previous close | US$1.49 |
|---|---|
| Market cap | US$160.12M |
| 52-week range | US$1.26 – US$6.87 |
| Volume | 81.01K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Nyxoah SA
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.
Year: 2021
Oppenheimer Adjusts Price Target on Nyxoah to $4 From $13, Maintains Outperform Rating
Aug 6, 1:49 PM · MT Newswires
Nyxoah Preliminary Q2 Revenue Rises From Q1; 2026 Outlook Reaffirmed
Jul 7, 8:36 PM · MT Newswires
Nyxoah Receives $15 Million From European Investment Bank
Jun 17, 8:39 PM · MT Newswires
Nyxoah SA (NYXH) stock is trading at US$1.48, -0.67% from the previous close of US$1.49.
The market cap for Nyxoah SA (NYXH) stock is approximately US$160.12M.
The 52-week high for Nyxoah SA (NYXH) stock is US$6.87.
The 52-week low for Nyxoah SA (NYXH) stock is US$1.26.
Nyxoah SA (NYXH) does not currently pay a dividend.
Stay on top of NYXH
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
